Clinical Trial Update: Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Saccharomyces boulardii with nystatin prophylaxis to prevent Candida colonization and infection in very low birth weight infant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections in Neonates
• Candidiasis

Drugs mentioned

• Nystatin (Nystatin)
• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Anticandidal Property of Saccharomyces Boulardii on Very Low Birth Weight Infants | Phase 4 | Status: UNKNOWN